Powder aerosol formulation of Pseudomonas aeruginosa bacteriophage for pulmonary delivery
- 16 April 2025
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 676, 125602
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research (R01HL167828)
- National Institutes of Health
- Division of Intramural Research (R01AI146160)
This publication has 30 references indexed in Scilit:
- Engineering the right formulation for enhanced drug deliveryAdvanced Drug Delivery Reviews, 2022
- Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilizationBioengineering & Translational Medicine, 2020
- Trileucine and Pullulan Improve Anti-Campylobacter Bacteriophage Stability in Engineered Spray-Dried MicroparticlesAnnals of Biomedical Engineering, 2019
- Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory InfectionsPharmaceutical Research, 2016
- Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infectionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled systemBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Spray-dried Respirable Powders Containing Bacteriophages for the Treatment of Pulmonary InfectionsJournal of Pharmaceutical Sciences, 2011
- Mechanisms of protein stabilization in the solid stateJournal of Pharmaceutical Sciences, 2009
- Trileucine Improves Aerosol Performance and Stability of Spray‐Dried Powders for InhalationJournal of Pharmaceutical Sciences, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007